We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Baskerville Capital Plc | LSE:BASK | London | Ordinary Share | GB00BDZRYX75 | ORD GBP0.005 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.45 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2021 08:57 | Well Oberon investments does look like an interesting business with some pretty distinguished management. Still not sure how one trade the shares but feeling more relaxed about the future. Anybody hanging on in here ? | wiloughby2 | |
30/1/2021 16:44 | Looks like I've been left holding the parcel in 'pass the parcel'.Has anyone had experience of trading on the Aquis exchange ?Is Baskerville one of those investments for the very back of the bottom drawer ? Thoughts of other holders appreciated ! | wiloughby2 | |
13/12/2019 15:58 | Is something going to happen at long last - bit of life in the old dog. | wantage | |
17/7/2018 19:13 | Baskerville Capital PLC is a newly-established company incorporated in England and Wales, formed for the purpose of acquiring a company or business with a technology focus that it would develop and grow. The Directors intend to concentrate on Acquisition opportunities on companies or businesses with a technology focus. That focus may be the result of the target, without limitation, having rights to a new piece of technology that has the potential to disrupt an existing market or as a result of the target developing software that has the potential to be licensed or rolled out on a global basis. The Company at this stage does not have a specific target in the technology space. However, the Company is particularly interested in targets in fin tech, med tech (excluding medical devices), bio tech, information technology and cloud computing. It is anticipated that the target may be valued at between £10 million and £100 million. The Company’s objective is to generate material returns for Shareholders, predominantly through capital appreciation, by taking advantage of opportunities to invest in the technology sector and operating the company or business it acquires. The Directors are responsible for carrying out this objective, implementing the Company’s business strategy and conducting its overall supervision. The Directors’ intention is to create a trading business, rather than an investment entity. The Directors consider the potential vendors of target companies or businesses will be attracted by the opportunity to own quoted equity in a London listed company with cash, access to the capital markets and the Director’s experience to develop their business. The Company’s efforts in identifying a prospective target company or business will not be limited to a particular geographic region except that it will avoid territories with significant geopolitical or economic risks such as certain countries in Africa, the Middle East and former Soviet Union. The likely initial focus will be the UK. The investment strategy of the Company will be focussed towards the identification and acquisition of a company or business which: is run by management with a strong track record of generating growth for shareholders and a proven experienced business record; has a compelling case for providing the foundation or platform for a scalable business which generates or the potential to generate substantial and sustainable free cash flow over time; has the ability to grow with additional capital or be replicated in other markets worldwide; has a sustainable competitive advantage or a unique selling proposition, perhaps arising from a technology that is in a high growth market; has the potential for a significant return for the Company’s shareholders; and can be funded adequately to allow the delivery of credible technological and commercial milestones, thus creating significant growth opportunities for Shareholders. The criteria set out above are not intended to be exhaustive. Any evaluation relating to the merits of a particular Acquisition will be based, to the extent relevant, on the above factors as well as other considerations deemed relevant to the Company’s business objective and strategy by the Directors. In evaluating a prospect for the Acquisition, the Company expects to carry out an appropriate due diligence review. | moneymunch | |
10/5/2018 07:51 | you can also add URA to that list of shell's...starting to show signs of life too! | undertaker | |
09/5/2018 09:37 | Shells we wish showed signs of life:CHA (suspended)RLH (delisted)MCC (delisted)We need BASK to make an investment. News, info and RNS are needed to get this share price on the move.GLA | raaf1978 | |
04/5/2018 16:13 | Shells finally showing signs of life today include BASK BLOC and YOLO all of which are either trading at discounts or skinny premiums to cash and NAV. other shells worth keeping an eye on include GOT and DERR. | chrisfillyourboots | |
01/2/2018 19:49 | Definitely an interesting speculation, seems very much under the radar too | robward | |
01/2/2018 18:07 | I hear good things. Remember some of chris' successes EVRH was an easy 10 bagger at 15p from Armstrong ventures. Stapleton was part of his stable.lets see how this one moves off the 2 furlong marker. | wantage | |
31/1/2018 14:37 | Pure punt because of Chris Akers connection a while ago. Haven't heard about TW tip. GLA | raaf1978 | |
31/1/2018 08:46 | I'm sure many of you are here only because of the TW tip....highly illiquild share which is a pure punt...let te discussion begin... | undertaker |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions